Certified by Founder Lodge
T-Therapeutics Ltd
United Kingdom - Cambridge
START UP
1 Disclosed Funding Rounds $59,707,000
0 Participating Investments
-
Founded date
2022
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
T-Therapeutics is a next-generation TCR company, spun out from the University of Cambridge, deeply rooted in world-leading academic science. We are developing ‘optimal’ TCR based therapeutic
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| November, 16 ,2023 | Series A | $59,707,000 |
Digitalis Ventures
F-Prime Capital
Sofinnova Partners
Cambridge Innovation Capital
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
